(Reuters) - U.S. healthcare plan and pharmacy benefits manager Magellan Health Inc will explore selling itself after coming under pressure to do so from activist hedge fund Starboard Value LP, people familiar with the matter said on Wednesday.
Magellan, advised by investment bank Goldman Sachs Group Inc, is in the early stages of considering acquisition interest expressed in the company, the sources said, cautioning there is no certainty a deal will materialize.
The sources asked not to be identified because the matter is confidential. Magellan and Goldman Sachs did not immediately respond to requests for comment.
(Reporting by Carl O'Donnell and Greg Roumeliotis in New York; Editing by Phil Berlowitz)
This story has not been edited by Firstpost staff and is generated by auto-feed.
The Great Diwali Discount!
Unlock 75% more savings this festive season. Get Moneycontrol Pro for a year for Rs 289 only.
Coupon code: DIWALI. Offer valid till 10th November, 2019 .
Updated Date: Feb 21, 2019 00:06:40 IST